Skip to content

Advertisement

  • Poster presentation
  • Open Access

Antinuclear antibodies (ANA) in a Colombian cohort of pediatric patients with autoimmune diseases (PAID)

  • 1Email author,
  • 2,
  • 3 and
  • 4
Pediatric Rheumatology20119 (Suppl 1) :P230

https://doi.org/10.1186/1546-0096-9-S1-P230

  • Published:

Keywords

  • Uveitis
  • Scleroderma
  • Antinuclear Antibody
  • Clinical Correlation
  • Pediatric Rheumatology

Background

ANA is an important diagnostic tool in PAID. The type of staining patterns by IFF technique and the final titer varies according of the type of PAID.

Aim

To evaluate the ANA type of patterns and titer on a cohort of PAID patients in a referral pediatric rheumatology center in Bogotá.

Methods

Retrospective descriptive study of a PAID cohort.

Results

363 patients were included. 66% had JIA, 11% JSLE, 7% juvenile undifferentiated autoimmune disease(JUAD), 4% Scleroderma, 4% JDM, 1% uveitis ANA + and a group of other PAID 11%. ANA positivity varies according to the subtype of JIA from 0-68%. Positive AAN: JSLE 93%, scleroderma 85%, JDM 63%. Most JUAD had ANA+ at low titers. A heterogeneous group of other PAID showed a variable titers and patterns of ANA .The most prevalent type of pattern was speckled, followed by homogenous and other pattern were uncommon. On JSLE, the prevalence and titers were higher and multiple auto antibodies were detected at the time of diagnosis. (Table 1).

Table 1

Disease

N

ANA+

Speckled

Homogeneous

≤1:320

>1:320

JIA

98/240

41%

96%

4%

91%

9%

JSLE

37/40

93%

70%

24%

35%

65%

JUAD

24/24

100%

83%

13%

63%

37%

JDM

8/13

62%

62%

38%

88%

12%

Scleroderma

11/13

85%

82%

18%

55%

45%

Other PAID

24/31

71%

71%

21%

67%

33%

Uveitis ANA+

3/3

100%

100%

0%

100%

0%

Conclusion

ANA positivity is not specific for PAID. Its interpretation should be based on a good clinical correlation and additional work up in order to classified and confirm PAID.

Authors’ Affiliations

(1)
Pediatric Rheumatology Fellowship program, Universidad el Bosque, Bogotá, Colombia
(2)
Pediatric Rheumatology Fellowship program, Universidad el Bosque, Bogotá, Colombia
(3)
Instituto UIBO, Universidad el Bosque, Bogotá, Colombia
(4)
Pediatric Rheumatology Fellowship program, Universidad el Bosque, Bogotá, Colombia

Copyright

Advertisement